Quarterly Transactions Made in Spdr Ser Tr Spdr S&P Biotech E (XBI)
This table provides information about the institutional ownership of Spdr Ser Tr Spdr S&P Biotech E (XBI). The information is specifically focused on institutions that hold shares of SPDR SER TR SPDR S&P BIOTECH E.
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q2 2022 | 18,132,175 | 9,520,590 | 27,652,765 | 15,562,090 | 4,290,761 | 19,852,851 | 7,799,914 | |
Q3 2022 | 8,676,511 | 5,165,464 | 13,841,975 | 16,114,916 | 28,899 | 16,143,815 | -2,301,840 | |
Q4 2022 | 14,999,573 | 9,494,260 | 24,493,833 | 9,274,277 | 10,841 | 9,285,118 | 15,208,715 | |
Q1 2023 | 21,882,923 | 2,069,865 | 23,952,788 | 17,377,684 | 72 | 17,377,756 | 6,575,032 | |
Q2 2023 | 16,373,836 | 2,138,686 | 18,512,522 | 16,304,472 | 0 | 16,304,472 | 2,208,050 | |
Q3 2023 | 12,940,191 | 3,358,391 | 16,298,582 | 4,961,292 | 29,567 | 4,990,859 | 11,307,723 | |
Q4 2023 | 10,086,652 | 10,027,192 | 20,113,844 | 34,198,483 | 72 | 34,198,555 | -14,084,711 | |
Q1 2024 | 30,595,542 | 3,814,299 | 34,409,841 | 14,615,521 | 0 | 14,615,521 | 19,794,320 | |
Q2 2024 | 13,111,960 | 1,950,837 | 15,062,797 | 18,396,224 | 161,891 | 18,558,115 | -3,495,318 | |
Q3 2024 | 15,529,050 | 4,677,405 | 20,206,455 | 8,691,459 | 1 | 8,691,460 | 11,514,995 | |
Q4 2024 | 23,894,433 | 9,195,490 | 33,089,923 | 20,292,638 | 170,100 | 20,462,738 | 12,627,185 | |
Q1 2025 | 16,868,919 | 4,530,874 | 21,399,793 | 10,893,914 | 15,761 | 10,909,675 | 10,490,118 | |
Q2 2025 | 15,880,880 | 1,121,552 | 17,002,432 | 13,946,262 | 0 | 13,946,262 | 3,056,170 |